These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 32943284)
1. Matrin-3 plays an important role in cell cycle and apoptosis for survival in malignant melanoma. Kuriyama H; Fukushima S; Kimura T; Okada E; Ishibashi T; Mizuhashi S; Kanemaru H; Kajihara I; Makino K; Miyashita A; Aoi J; Okada S; Ihn H; Kita K J Dermatol Sci; 2020 Nov; 100(2):110-119. PubMed ID: 32943284 [TBL] [Abstract][Full Text] [Related]
2. Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells. Mizuhashi S; Fukushima S; Ishibashi T; Kuriyama H; Kimura T; Kanemaru H; Kajihara I; Makino K; Miyashita A; Aoi J; Kita K; Ihn H J Dermatol Sci; 2021 Apr; 102(1):16-24. PubMed ID: 33583643 [TBL] [Abstract][Full Text] [Related]
3. Matrin-3 is essential for fibroblast growth factor 2-dependent maintenance of neural stem cells. Niimori-Kita K; Tamamaki N; Koizumi D; Niimori D Sci Rep; 2018 Sep; 8(1):13412. PubMed ID: 30194346 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Investigation into the Role of Ubiquitin-Conjugating Enzyme E2S in Melanoma Development. Wang P; Li Y; Ma Y; Zhang X; Li Z; Yu W; Zhu M; Wang J; Xu Y; Xu A J Invest Dermatol; 2021 Feb; 141(2):374-384. PubMed ID: 32603752 [TBL] [Abstract][Full Text] [Related]
5. p54nrb is a new regulator of progression of malignant melanoma. Schiffner S; Zimara N; Schmid R; Bosserhoff AK Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354 [TBL] [Abstract][Full Text] [Related]
6. Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells. Bai M; Yu NZ; Long F; Feng C; Wang XJ Cell Physiol Biochem; 2016; 40(6):1367-1376. PubMed ID: 27997910 [TBL] [Abstract][Full Text] [Related]
7. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression. Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173 [TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750 [TBL] [Abstract][Full Text] [Related]
9. Matrin 3 as a key regulator of endothelial cell survival. Przygodzka P; Boncela J; Cierniewski CS Exp Cell Res; 2011 Apr; 317(6):802-11. PubMed ID: 21182838 [TBL] [Abstract][Full Text] [Related]
10. EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle. Zheng W; Li Y; Su Z; Zhang J; Shi F; Liang W Exp Cell Res; 2021 May; 402(1):112488. PubMed ID: 33508274 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of NLE1 inhibits development of malignant melanoma in vitro and in vivo NLE1 promotes development of malignant melanoma. Ren Z; Ni F; Zhang T; Yuan X; Li J; Xiao W Exp Cell Res; 2021 Jul; 404(2):112636. PubMed ID: 34019907 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma. Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of enhancer of rudimentary homolog expression attenuates proliferation, cell cycle and apoptosis of melanoma cells. Xiao M; Tang N; Yan Y; Li Z; Shi S; He S; Chen Z; Cao K; Chen J; Zhou J; Chen X Melanoma Res; 2021 Aug; 31(4):309-318. PubMed ID: 34193803 [TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cells. Song Z; Lin J; Sun Z; Ni J; Sha Y J Dermatol Sci; 2015 Jul; 79(1):57-63. PubMed ID: 25920913 [TBL] [Abstract][Full Text] [Related]
15. The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy. Hao J; Xu H; Luo M; Yu W; Chen M; Liao Y; Zhang C; Zhao X; Jiang W; Hou S; Feng X; Zou K; Chen Y; Huang W; Guo W; Kang L; Deng W J Invest Dermatol; 2018 Jan; 138(1):159-170. PubMed ID: 28899685 [TBL] [Abstract][Full Text] [Related]
16. Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-[Formula: see text]B and Mitochondria-Dependent Pathways In Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model In Vivo. Shiue YW; Lu CC; Hsiao YP; Liao CL; Lin JP; Lai KC; Yu CC; Huang YP; Ho HC; Chung JG Am J Chin Med; 2016; 44(3):637-61. PubMed ID: 27109154 [TBL] [Abstract][Full Text] [Related]
17. DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis. Xu Y; Sun W; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Chen Y Exp Cell Res; 2019 Jun; 379(1):48-54. PubMed ID: 30880030 [TBL] [Abstract][Full Text] [Related]
18. Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells. Montagnani Marelli M; Marzagalli M; Moretti RM; Beretta G; Casati L; Comitato R; Gravina GL; Festuccia C; Limonta P Sci Rep; 2016 Jul; 6():30502. PubMed ID: 27461002 [TBL] [Abstract][Full Text] [Related]
20. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study. Yu SJ; Long ZW Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]